Related Experiment Videos
Myeloma and pernicious anemia.
The American Journal of the Medical Sciences
|January 1, 1978
Summary
This study suggests a link between pernicious anemia and multiple myeloma, highlighting a potential causative relationship. Screening for vitamin B12 deficiency in gammopathy patients and protein issues in pernicious anemia patients is recommended.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Pernicious anemia is an autoimmune condition affecting vitamin B12 absorption.
- Multiple myeloma is a cancer of plasma cells, often associated with monoclonal gammopathies.
Observation:
- Four new cases of pernicious anemia co-occurring with multiple myeloma were identified.
- A total of 14 cases now demonstrate this association, suggesting a potential causative link.
Findings:
- The co-occurrence of pernicious anemia and multiple myeloma is more frequent than expected by chance.
- This association aligns with known links between pernicious anemia and other gammopathies like benign monoclonal gammopathy and hypoglobulinemia.
Implications:
- Screening for vitamin B12 deficiency is crucial in patients diagnosed with gammopathies.
- Patients with pernicious anemia should be evaluated for underlying protein abnormalities or related conditions.